Related Experiment Video
Updated: May 13, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Anemia Management in Pediatric Chronic Kidney Disease: Current Challenges and Treatment Strategies
Altaf Jamil1, Barbara Gruner1, Javairia Jamil2
1Department of Pediatrics, Division of Hematology and Oncology, University of Missouri School of Medicine, Columbia, MO USA.
Insights
Iron deficiency anemia (IDA) is common in pediatric chronic kidney disease (CKD) but often overlooked. Effective management with iron and erythropoiesis-stimulating agents (ESAs) improves outcomes, though diagnosis and treatment targets remain challenging.
Area of Science:
- Nephrology
- Pediatrics
- Hematology
Background:
- Iron deficiency anemia (IDA) is a frequent complication in pediatric chronic kidney disease (CKD).
- Anemia in pediatric CKD is linked to reduced quality of life and increased morbidity/mortality.
- Causes include low erythropoietin (EPO) production, iron deficiency, and inflammation (high hepcidin).
Purpose of the Study:
- To review the complexities of managing anemia in pediatric CKD.
- To highlight the role of iron supplementation and ESAs in treatment.
- To discuss challenges in diagnosis and setting treatment goals.
Main Methods:
- Literature review on anemia in pediatric CKD.
- Analysis of iron supplementation and ESA efficacy.
- Discussion of diagnostic and therapeutic challenges.
Main Results:
- Intravenous (IV) iron effectively treats iron-restricted erythropoiesis and improves ESA response.
- Anemia management in pediatric CKD is complex due to multiple factors.
- Accurate diagnosis and target setting for anemia in this population are ongoing challenges.
Conclusions:
- Iron supplementation and ESAs are crucial for managing anemia in pediatric CKD.
- Addressing iron deficiency is key to optimizing erythropoiesis and patient outcomes.
- Further research is needed to refine diagnostic criteria and treatment targets for anemia in pediatric CKD.
Abstract:
A prevalent complication of chronic kidney disease (CKD), iron deficiency anemia (IDA) continues to be underdiagnosed and undertreated. Anemia in CKD in children is associated with a reduced quality of life, and an increased morbidity and mortality. The multifaceted etiology of anemia in CKD involves factors such as diminished endogenous erythropoietin (EPO) production, absolute or functional iron deficiency, and heightened inflammation characterized by elevated hepcidin levels. This paper reviews the complexities of anemia management in pediatric CKD, emphasizing the pivotal role of iron supplementation and erythropoiesis-stimulating agents (ESAs) in ameliorating erythropoiesis and optimizing patient outcomes. While intravenous (IV) iron supplementation effectively addresses iron-restricted erythropoiesis and enhances ESA response, challenges persist in accurately defining anemia in pediatric CKD patients and establishing appropriate treatment targets.
Related Concept Videos
Hormonal Regulation
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

